P184 A 24-month prospective psoriatic arthritis observational study of persistence of treatment - interim analysis of baseline characteristics

Autor: Jacques Morel, Lorenzo Dagna, Beatriz Joven Ibañez, Thorsten Holzkaemper, Celine El Baou, Leonore Unger, Angelo Semeraro, Nicola Gullick, Tamas Treuer

Publikováno v: Rheumatology. 62

Background/Aims Ixekizumab (ixe), a highly selective interleukin (IL)-17A monoclonal antibody, has been approved for treatment of psoriatic arthritis (PsA). However, there is limited real-world evidence (RWE) available for ixe. PRO-SPIRIT is the firs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cab04e4130b1adfc972fbc3f9de895b6
https://doi.org/10.1093/rheumatology/kead104.225

Differenzialdiagnose ausgedehnter ossärer Destruktionen – ein Fallbericht

Autor: M. Kayser, Leonore Unger, Kristin Engel

Publikováno v: Aktuelle Rheumatologie. 46:57-61

ZusammenfassungDie Gicht ist die häufigste metabolische Arthropathie. Obwohl Ätiologie und Pathogenese des Krankheitsbildes gut untersucht sind, bereitet die Diagnosesicherung mittels des Nachweises von Natriumuratkristallen aus einem Gelenkpunktat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9a96558f8ec218927a271489b1ad2c62
https://doi.org/10.1055/a-1226-8575

Psyche und Rheuma

Autor: Leonore Unger

Publikováno v: Aktuelle Rheumatologie. 46:205-205

Psychische Störungen sind bei rheumatischen Erkrankungen häufig und beide beeinflussen sich gegenseitig.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::53933dc9135e1be9cd911b6f0ca1cae0
https://doi.org/10.1055/a-1295-3881

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Autor: Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd-Ruediger Burmester, David H Adams, Lisa Kerr, Chin Lee, Catherine L Shuler, Mark Genovese, Khalid Ahmed, Jeffrey Alper, Nichol Barkham, Ralph E. Bennett, Francisco Javier Blanco García, Ricardo Blanco Alonso, Howard B. Blumstein, Michael S. Brooks, Gerd-Rüdiger Burmester, Patricia Cagnoli, Paul H. Caldron, Alain Cantagrel, Der-Yuan Chen, Melvin A. Churchill, Christine E. Codding, Peter M.G. Deane, Jose Del Giudice, Atul A. Deodhar, Rajat K. Dhar, Eva Dokoupilova, Rita M. Egan, Andrea Everding, Eva Galíndez, David H. Goddard, Alice Gottlieb, Philippe Goupille, Robert M. Griffin, Ramesh C. Gupta, Stephen Hall, Kalpita Hatti, Mary P. Howell, Yu-Huei Huang, Ramina Jajoo, Namieta M. Janssen, Uta Kiltz, Alan J. Kivitz, Steven J. Klein, Mariusz P. Korkosz, Roshan Kotha, Joel M. Kremer, Cummins Lue, José Luis Marenco de la Fuente, Helena Marzo-Ortega, Jordi Gratacós Masmitja, Philip J. Mease, Pier Luigi Meroni, Eric C. Mueller, Anupama C. Nandagudi, Antonio Fernández-Nebro, Clark M. Neuwelt, Ana Maria Orbai, Meera R. Oza, Deborah L. Parks, Debendra Pattanaik, Maria E. Rell-Bakalarska, David Rosmarin, Euthalia Roussou, Anna I. Rychlewska-Hanczewksa, David H. Sikes, Michael T. Stack, Prashanth Sunkureddi, Hasan Tahir, Diamant Thaçi, Tsen-Fang Tsai, Anthony M. Turkiewicz, Leonore Unger, Raúl Veiga Cabello, Ulf Wagner, Cheng-Chung Wei, Alvin F. Wells, Peter Youssef, Agnieszka Zielinska

Publikováno v: Lancet (London, England). 389(10086)

Patients who have had inadequate response to tumour necrosis factor inhibitors have fewer treatment options and are generally more treatment refractory to subsequent therapeutic interventions than previously untreated patients. We report the efficacy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e86bed9c822e2b158c34f88e2aa99b8
https://pubmed.ncbi.nlm.nih.gov/28592895

Psoriatic arthritis

Autor: Uwe Wollina, Leonore Unger, Birgit Heinig, Thomas Kittner

Publikováno v: Dermatologic Therapy. 23:123-136

Psoriatic arthritis (PSA) is an entity of inflammatory joint disease associated with psoriasis. PSA belongs to the heterogeneous group of seronegative spondylarthropathies. Both peripheral joints and axial skeleton can be affected in a characteristic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b38d673c4f2da3148a60cfe0c2db0ff3
https://doi.org/10.1111/j.1529-8019.2010.01306.x